30.09.2021 • News

Saudi Groups SIIG and Petrochem Propose Merger

Saudi Industrial Investment Group (SIIG) and the National Petrochemical Company (Petrochem) have signed a non-binding Memorandum of Understanding (MoU) to assess the economic feasibility of a merger between the two firms.

The transaction would be implemented through a share exchange offer with Petrochem's shareholders receiving 1.27 shares in SIIG in exchange for each Petrochem share. If the deal goes through, Petrochem’s shares will be de.listed from the Tadawul and it will become a wholly owned subsidiary of SIIG.

A merger remains subject to regulatory approvals, as well as approval by each company’s shareholders.

The companies have talked twice before about a merger. They entered discussions last year, but had previously talked as far back as 2011, when in June of that year both companies said they would postpone such a move until at least end 2011 when a joint venture started production. That jv is Saudi Polymers, a partnership between Petrochem and Chevron Phillips Chemical. Petrochem owns 65% in Saudi Polymers, while SIIG also owns 50% of Saudi Chevron Phillips and Jubail Chevron Phillips.

Author: Elaine Burridge, Freelance Journalist

Saudi Industrial Investment Group and the National Petrochemical Company...
Saudi Industrial Investment Group and the National Petrochemical Company (Petrochem) have signed a non-binding agreement to assess the feasibility of a merger. If finalized, Petrochem’s shares will be de-listed from the Tadawul and it will become a wholly owned subsidiary of SIIG. (c) Petrochem

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.